Individual testosterone decline and future mortality risk in men
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Individual testosterone decline and future mortality risk in men. / Holmboe, Stine Agergaard; Skakkebaek, Niels E.; Juul, Anders; Scheike, Thomas; Jensen, Tina Kold; Linneberg, Allan; Thuesen, Betina H.; Andersson, Anna-Maria.
In: European Journal of Endocrinology, Vol. 178, 01.2018, p. 121-128.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Individual testosterone decline and future mortality risk in men
AU - Holmboe, Stine Agergaard
AU - Skakkebaek, Niels E.
AU - Juul, Anders
AU - Scheike, Thomas
AU - Jensen, Tina Kold
AU - Linneberg, Allan
AU - Thuesen, Betina H.
AU - Andersson, Anna-Maria
PY - 2018/1
Y1 - 2018/1
N2 - OBJECTIVE: Male aging is characterized by a decline in testosterone (T) levels with a substantial variability between subjects. However, it is unclear whether differences in age-related changes in T are associated with general health. We investigated associations between mortality and intra-individual changes in serum levels of total T, SHBG, free T, estradiol and LH during a ten year period with up to 18 years of registry follow-up.DESIGN: 1,167 men aged 30 to 60 years participating in the Danish Monitoring Trends and Determinants of Cardiovascular Disease (MONICA1) study and who had a follow-up examination ten years later (MONICA10) were included. From MONICA10 the men were followed up to 18 years (mean: 15.2 years) in national mortality registries via their unique personal ID number.METHODS: Cox proportional hazard models were used to investigate the association between intra-individual hormone changes and all-cause-, CVD-, and cancer mortality.RESULTS: A total of 421 men (36.1%) died during the follow-up period. Men with most pronounced decline in total T (<10th percentile) had a higher all-cause mortality risk compared to men within the 10th to 90th percentile (hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.08-2.36). No consistent associations were seen in cause-specific mortality analyses.CONCLUSION: Our study showed that higher mortality rates were seen among the men who had the most pronounced age-related decline in T, independent of their baseline T levels.
AB - OBJECTIVE: Male aging is characterized by a decline in testosterone (T) levels with a substantial variability between subjects. However, it is unclear whether differences in age-related changes in T are associated with general health. We investigated associations between mortality and intra-individual changes in serum levels of total T, SHBG, free T, estradiol and LH during a ten year period with up to 18 years of registry follow-up.DESIGN: 1,167 men aged 30 to 60 years participating in the Danish Monitoring Trends and Determinants of Cardiovascular Disease (MONICA1) study and who had a follow-up examination ten years later (MONICA10) were included. From MONICA10 the men were followed up to 18 years (mean: 15.2 years) in national mortality registries via their unique personal ID number.METHODS: Cox proportional hazard models were used to investigate the association between intra-individual hormone changes and all-cause-, CVD-, and cancer mortality.RESULTS: A total of 421 men (36.1%) died during the follow-up period. Men with most pronounced decline in total T (<10th percentile) had a higher all-cause mortality risk compared to men within the 10th to 90th percentile (hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.08-2.36). No consistent associations were seen in cause-specific mortality analyses.CONCLUSION: Our study showed that higher mortality rates were seen among the men who had the most pronounced age-related decline in T, independent of their baseline T levels.
KW - Journal Article
U2 - 10.1530/EJE-17-0280
DO - 10.1530/EJE-17-0280
M3 - Journal article
C2 - 29066571
VL - 178
SP - 121
EP - 128
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
SN - 0804-4643
ER -
ID: 185406016